Tags

Type your tag names separated by a space and hit enter

Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis.
Mater Med Pol. 1991 Jul-Sep; 23(3):203-8.MM

Abstract

The aim of the study was the evaluation of the efficacy of calcium carbonate (CaCO3) in the control of serum phosphorus level in children with ESRD. Sixteen patients (group I) were evaluated retrospectively, 25 pts (group II) were observed prospectively. The pts from group I were treated with CaCO3 (100-800 mg/kg/day) with or without Al(OH)3 and with different doses of DHT. The pts from group II were treated with CaCO3 and DHT without Al(OH)3 but some of them had obtained Al(OH)3 in the past. The doses of CaCO3 were individually adjusted to maintain the serum calcium level 5.0-5.5 mEq/l. In the pts on CAPD evaluated retrospectively the control of serum phosphorus level was better and episodes of hypercalcemia were more frequent than in the pts on HD. Neither the concomitant use of Al(OH)3 with CaCO3 nor varying the dosage of DHT within assumed range influenced serum phosphorus level. The differences in serum phosphorus level and in the frequency of episodes of hypercalcemia in pts in group II were less obvious then in group I. It may depend on more precise adjustment of CaCO3 doses to the individual needs of these pts. The episodes of hypercalcemia in the group II were more frequent in pts who received Al(OH)3 in the past.

Authors+Show Affiliations

Department of Paediatrics and Nephrology, Medical Academy, Warszawa, Poland.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

1842716

Citation

Sieniawska, M, et al. "Calcium Carbonate as a Phosphate Binder in Children On Continuous Ambulatory Peritoneal Dialysis and Hemodialysis." Materia Medica Polona. Polish Journal of Medicine and Pharmacy, vol. 23, no. 3, 1991, pp. 203-8.
Sieniawska M, Roszkowska-Blaim M, Weglarska J, et al. Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis. Mater Med Pol. 1991;23(3):203-8.
Sieniawska, M., Roszkowska-Blaim, M., Weglarska, J., Jabłczyńska, A., & Welc-Dobies, J. (1991). Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis. Materia Medica Polona. Polish Journal of Medicine and Pharmacy, 23(3), 203-8.
Sieniawska M, et al. Calcium Carbonate as a Phosphate Binder in Children On Continuous Ambulatory Peritoneal Dialysis and Hemodialysis. Mater Med Pol. 1991 Jul-Sep;23(3):203-8. PubMed PMID: 1842716.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis. AU - Sieniawska,M, AU - Roszkowska-Blaim,M, AU - Weglarska,J, AU - Jabłczyńska,A, AU - Welc-Dobies,J, PY - 1991/7/1/pubmed PY - 1991/7/1/medline PY - 1991/7/1/entrez SP - 203 EP - 8 JF - Materia medica Polona. Polish journal of medicine and pharmacy JO - Mater Med Pol VL - 23 IS - 3 N2 - The aim of the study was the evaluation of the efficacy of calcium carbonate (CaCO3) in the control of serum phosphorus level in children with ESRD. Sixteen patients (group I) were evaluated retrospectively, 25 pts (group II) were observed prospectively. The pts from group I were treated with CaCO3 (100-800 mg/kg/day) with or without Al(OH)3 and with different doses of DHT. The pts from group II were treated with CaCO3 and DHT without Al(OH)3 but some of them had obtained Al(OH)3 in the past. The doses of CaCO3 were individually adjusted to maintain the serum calcium level 5.0-5.5 mEq/l. In the pts on CAPD evaluated retrospectively the control of serum phosphorus level was better and episodes of hypercalcemia were more frequent than in the pts on HD. Neither the concomitant use of Al(OH)3 with CaCO3 nor varying the dosage of DHT within assumed range influenced serum phosphorus level. The differences in serum phosphorus level and in the frequency of episodes of hypercalcemia in pts in group II were less obvious then in group I. It may depend on more precise adjustment of CaCO3 doses to the individual needs of these pts. The episodes of hypercalcemia in the group II were more frequent in pts who received Al(OH)3 in the past. SN - 0025-5246 UR - https://www.unboundmedicine.com/medline/citation/1842716/Calcium_carbonate_as_a_phosphate_binder_in_children_on_continuous_ambulatory_peritoneal_dialysis_and_hemodialysis_ L2 - https://medlineplus.gov/dialysis.html DB - PRIME DP - Unbound Medicine ER -